Medicine and Dentistry
Prostate Cancer
100%
Bladder Cancer
72%
Bladder
60%
Cystectomy
48%
Biopsy Technique
33%
Malignant Neoplasm
33%
Neoplasm
33%
Randomized Controlled Trial
30%
Urology
30%
Metastatic Carcinoma
29%
Diseases
28%
Non Muscle Invasive Bladder Cancer
28%
Prospective Cohort Study
27%
Prostate Biopsy
27%
Transrectal Ultrasonography
26%
Transitional Cell Carcinoma
26%
Urothelial Cancer
24%
Microhematuria
23%
Durvalumab
23%
Cancer
23%
Radiation Therapy
22%
Quality of Life
21%
Computer Assisted Tomography
20%
Prostate Specific Antigen
20%
Androgen Deprivation Therapy
19%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Infection
19%
Disease Exacerbation
18%
Pelvis
16%
Clear Cell Renal Cell Carcinoma
15%
Prostatectomy
15%
Patient Referral
15%
Immunotherapy
14%
Recurrent Disease
14%
Mycobacterium Bovis BCG
14%
Colic
13%
Medicine
13%
Clinical Trial
13%
Arm
13%
Orchiectomy
13%
COVID-19
13%
Placebo
13%
Muscle Invasive Bladder Cancer
13%
Kidney Injury
12%
Medical Oncology
11%
Intravesical Drug Administration
11%
Cancer Surgery
11%
Shared Care
11%
Seminoma
11%
Pelvic Radiotherapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
33%
Non Muscle Invasive Bladder Cancer
25%
Durvalumab
17%
Prostate Cancer
13%
Mycobacterium Bovis BCG
13%
Muscle Invasive Bladder Cancer
13%
Diseases
12%
Malignant Neoplasm
11%
Clinical Trial
11%
SARS Coronavirus
11%
Prospective Cohort Study
11%
Transitional Cell Carcinoma
11%
Recurrent Disease
11%
Chemotherapy
9%
Androgen
8%
Prevalence
7%
Infection
7%
Adverse Event
7%
Tolerability
7%
Prostate Specific Antigen
6%
Leuprorelin
6%
Immunoassay
5%
Gonadorelin Derivative
5%
Urinary Tract Infection
5%
Phosphodiesterase Inhibitor
5%
Nanomedicine
5%
Bisphosphonic Acid Derivative
5%
Melena
5%
Pembrolizumab
5%
Chemoradiation Therapy
5%
Venous Thromboembolism
5%
Placebo
5%
Iron Deficiency Anemia
5%
Bone Metastasis
5%
Hyaluronic Acid
5%
Finasteride
5%
Chondroitin Sulfate
5%
Ureter Stone
5%
Opiate
5%
Spinal Cord Injury
5%
Mitomycin
5%
Erectile Dysfunction
5%
Overall Survival
5%
Side Effect
5%
Nursing and Health Professions
Prostate Cancer
51%
Hospital
25%
Androgen Deprivation Therapy
19%
Systematic Review
11%
Bladder Cancer
11%
Prostatectomy
11%
Diagnosis
11%
Fat Mass
11%
Prostate Specific Antigen
9%
Body Composition
9%
Cancer Incidence
8%
Muscle Strength
8%
Obesity
8%
Patient Referral
8%
Surgeon
8%
Cancer Survival
6%
General Anesthesia
5%
Health Care Personnel
5%
Radical Retropubic Prostatectomy
5%
Telehealth
5%
Operating Room
5%
Severe Acute Respiratory Syndrome
5%
Cancer Localization
5%
Prospective Cohort Study
5%
Disease Exacerbation
5%
Bone Density
5%
Infection
5%
Network Meta-Analysis
5%
Non Muscle Invasive Bladder Cancer
5%
Immunoassay
5%
Cancer Diagnosis
5%
Androgen
5%
Systematic Review with Meta-Analysis
5%
Recurrent Disease
5%
Colorectal Carcinoma
5%
Nutrition Policy
5%
Cystectomy
5%